tolbutamide has been researched along with Erythroblastosis Fetalis in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Göres, E | 1 |
| Kiesewetter, R | 1 |
| Kahl, GF | 1 |
2 other studies available for tolbutamide and Erythroblastosis Fetalis
| Article | Year |
|---|---|
[Dangers in drug combinations].
Topics: Dicumarol; Dosage Forms; Drug Antagonism; Drug Interactions; Drug Synergism; Erythroblastosis, Fetal | 1972 |
[Changes in the velocity of drug catabolism and their importance in drug therapy].
Topics: Administration, Oral; Age Factors; Alcohols; Anticoagulants; Anticonvulsants; Carcinogens; Contracep | 1971 |